What PhotonMed does

PhotonMed is an EU-funded research consortium project that advances photonics technologies for innovative medical device applications, led by VTT Technical Research Centre of Finland Ltd. The project operates a pilot line R&D model inherited and scaled from the preceding MedPhab project, with the explicit objective of reducing time-to-market for photonics-based medical devices by addressing know-how gaps, fragmented technology offerings, and regulatory friction early in the development cycle. The consortium brings together 36 partners across 8 European countries (Belgium, Cyprus, Finland, France, Germany, Ireland, Netherlands, Switzerland), combining research and technology organizations (VTT, CSEM, Imec, Tyndall), industrial suppliers, equipment vendors, and end-user companies to cover the full development chain from concepting to industrial fabrication.

PhotonMed's technical work targets three application domains — in vitro diagnostics, in vivo diagnostics, and personalized monitoring — through 15-16 end-user-led pilot cases spanning point-of-care pathogen detection, OCT imaging for bladder cancer and intravascular applications, ophthalmic laser treatment, catheter-based cardiovascular monitoring, and wearable health/breath analysis devices. The project's technology pipeline targets 10 new photonics component technologies, 11 integration technologies, and 3 new assembly units for pilot line fabrication, validated up to TRL5 demonstrators through stakeholder-led requirement-to-validation chains. Key partners include Philips as a major end-user, Sanmina Corporation as a contract electronics manufacturer in an ISO 13485-certified environment, and silicon nitride PIC specialists such as Ligentec and equipment vendors including Ficontec.

PhotonMed is not a commercial company and has no disclosed revenue or pricing model. It is co-funded by the EU Chips Joint Undertaking with national top-up funding from Finland, Germany, The Netherlands, Belgium, Ireland, France, Cyprus, and the Swiss Confederation (SERI). Technologies developed within the project are appended to the MedPhab pilot line offering and made available to companies outside the consortium via an open access policy, positioning the initiative as a long-term European infrastructure asset rather than a transactional R&D effort. Dissemination occurs through the project website, LinkedIn, conference presentations at venues including Biosensors 2025, ECIO 2025, Photonics West 2026, and EOSAM 2026, and publications in journals including ACS Omega.

Name

PhotonMed

Legal name

PhotonMed Project, VTT Technical Research Centre of Finland

Website

https://photonmed.eu

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1–10 employees

Short description

PhotonMed is an EU-funded research consortium led by VTT that advances photonics technologies for medical devices, operating a 36-partner pilot line across 8 European countries to validate 15-16 end-user-led pilot cases in diagnostics and personalized monitoring.

Ownership category

akta.pro rank

Product category

Photonics Medical Device Research

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

SIC

Optical Instruments & Lenses (3827), Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Optoelectronic Receivers & Transceivers (Photodetectors/Optical Modules) (HDAHALAM)

akta.pro secondary industries

Optoelectronic Emitters (LED/Laser/VCSEL) (HDAHALAL), Optical Dispensing & Eyewear Devices (Frames, Lenses, Lens Edging/Finishing Equipment) (HLAHAJAD)

Keywords

• Photonics medical devices
• Medical photonics research
• Pilot line fabrication
• Photonics integration technologies
• Medical device R&D

Headquarters

HQ city

Espoo

HQ country

Finland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales

Distribution channels1 record

Marketing channels3 records

Core offering

PhotonMed is an EU-funded research consortium project that develops and validates photonics technologies for medical device applications through a pilot line R&D model inherited from MedPhab. The project produces new photonics component technologies, integration technologies, and assembly units, and validates them in 16 pilot cases led by end-user companies across in vitro diagnostics, in vivo diagnostics, and personalized monitoring domains. Developed technologies are appended to a sustainable pilot line offering made available to external companies via an open access policy.

Product overview

PhotonMed is a European research consortium project focused on advancing photonics technologies for medical device applications. Rather than offering commercial products, the project facilitates the development and validation of photonics technologies through 16 pilot cases led by end-user consortium partners across three application domains: in vitro diagnostics, in vivo diagnostics, and personalized monitoring. The project operates a pilot line R&D model that makes developed technologies available to companies via open access policy, reducing time-to-market for end-user companies.

Differentiator

Problem solved

Functional benefit

Products and services

• PhotonMed Pilot Line R&D Model

Quantifiable outcome

• 15 pilot cases across three medical device fields using eight technology value chain blocks
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

21 partnerships are on record, tiered core - lead coordinator, core partner, core partner - end user, core partner - manufacturing partner, technology partner and foundational.

• VTT Technical Research Centre of Finland Ltd.core - lead coordinatorStrategic or Co-development PartnerProject lead and coordinator of PhotonMed. VTT is a Finnish research organization that serves as the data controller for the project website and hosts the pilot line infrastructure.
• CSEMcore partnerStrategic or Co-development PartnerSwiss research organization specializing in microtechnology, part of the 36-partner consortium working on photonics technologies for medical devices.
• Imeccore partnerStrategic or Co-development PartnerBelgian research organization focused on nanoelectronics and digital technologies, contributing to photonics integration for medical device applications.
• Philipscore partner - end userStrategic or Co-development PartnerMulti-national health technology company serving as end-user in pilot cases including OCT imaging and clinical training instruments for pelvic pain diagnosis.
• Tyndall National Institutecore partnerStrategic or Co-development PartnerIrish research center contributing to catheter micro-imager development and hypoxia monitoring device research within the consortium.
• Erasmus MCcore partnerStrategic or Co-development PartnerDutch university medical center involved in intravascular imaging pilot cases and clinical validation of photonics-based diagnostic technologies.
• Sanmina Corporationcore partner - manufacturing partnerStrategic or Co-development PartnerWorld-class contract electronics manufacturer (CEM) responsible for device manufacturing and assembly within GMP and ISO 13485-certified environment for hypoxia sensing devices.
• Ligentectechnology partnerTechnology or IntegrationSwiss company specializing in silicon nitride photonic integrated circuits for medical diagnostics, contributing to OCT imaging technology development.
• Scinvivocore partner - end userStrategic or Co-development PartnerCompany developing Lumante OCT imaging system for bladder cancer characterization, using integrated photonics with on-chip source, interferometer and detection.
• Ficontectechnology partnerTechnology or IntegrationCompany developing automated packaging processes for miniaturized optical probes for catheter-based in-vivo surgical guidance.
• Surfixcore partner - end userStrategic or Co-development PartnerCompany developing photonic IVD platform based on biochips for point-of-care biomarker testing, advancing from RUO system to IVDR certified diagnostic platform.
• MEEPcore partner - end userStrategic or Co-development PartnerCompany developing at-home minilab using silicon photonics technology for on-the-spot health parameter testing with reusable reader and disposable test.
• Qurincore partner - end userStrategic or Co-development PartnerCompany developing fast urine sample preparation method for cfDNA and gDNA concentration for point-of-care diagnostics, primarily for bladder cancer detection.
• Bialoomcore partner - end userStrategic or Co-development PartnerCompany developing multimodal blood diagnostics for point-of-care application to accelerate diagnosis of acute blood infections and sepsis.
• CUROLEDcore partner - end userStrategic or Co-development PartnerCompany developing innovative photomedical smart textile wearables for joint and muscular health using flexible LED-based therapy systems.
• Polarcore partner - end userStrategic or Co-development PartnerCompany developing lasers and photonic modules for personalized monitoring wearables at VIS to MIR wavelengths, with focus on dehydration monitoring applications.
• Maculasercore partner - end userStrategic or Co-development PartnerCompany developing ophthalmic laser system for age-related macular degeneration and diabetic retinopathy with real-time patient-specific thermal dosing.
• Kaminari Medicalcore partner - end userStrategic or Co-development PartnerCompany developing intravascular ultrasound and photoacoustic (IVPA) dual modality imaging device combining IVUS and IVPA in one catheter for cardiac imaging.
• Gaseracore partner - end userStrategic or Co-development PartnerCompany miniaturizing ultra-sensitive cantilever-enhanced photoacoustic technology into continuous-flow platform for breath analysis with sensor cell under 10mm.
• Maastricht Universitycore partnerStrategic or Co-development PartnerUniversity contributing to photonic technologies for clinical training instruments measuring sexual arousal biomarkers for female pelvic pain diagnosis.
• MedPhabfoundationalStrategic or Co-development PartnerPrevious EU-funded project that established the successful pilot line R&D model now exploited in PhotonMed. PhotonMed builds upon MedPhab's operational infrastructure.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/photonmed

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PhotonMed